BOSTON, April 16, 2025: Morgan Lewis is advising Manus, a leading bioalternatives scale-up platform, on a strategic merger agreement with life sciences technology company Inscripta.
Manus works with companies across industries and value chains to accelerate the transition to bioalternatives. Inscripta develops sustainable and affordable biomanufacturing solutions for a variety of applications and industries.
Morgan Lewis partner Michael Barron, of counsel Brian Slough, and associates LaVelle King, Lucas Salada, and Michelle Kennedy are advising Manus.